These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8054917)

  • 21. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654].
    Lamana M; Fernández-Rañada JM
    Sangre (Barc); 1991 Dec; 36(6):501-3. PubMed ID: 1812583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
    Genevay MC; Mormont C; Thomas F; Berthier R
    Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Granulocytic progenitors in bone marrow autografts].
    Maraninchi D; Sebahoun G; Chauvet M; Gastaut JA; Novakovitch G; Kulling G; de Chesse R; Forgues L; Mascret B; Carcassonne Y
    Nouv Rev Fr Hematol (1978); 1983; 25(4):235-9. PubMed ID: 6353372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
    Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
    Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation.
    Podestà M; Piaggio G; Frassoni F; Pitto A; Mordini N; Bregante S; Valeriani A; Bacigalupo A
    Bone Marrow Transplant; 1997 May; 19(10):1011-7. PubMed ID: 9169645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-2 effects on allogeneic and autologous transplant haemopoietic progenitors in long-term cultures.
    López-Jiménez J; Quiroga R; Ramos P; Cerveró C; Parra C; García-Laraña J; Pérez-Oteyza J; Roldán E; Heindrichs B; Odriozola J
    Bone Marrow Transplant; 1996 Nov; 18(5):899-905. PubMed ID: 8932843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of hemopoietic progenitor cells in bone marrow and peripheral blood samples which have undergone different periods of cryopreservation].
    Bianchi de Di Risio CC; Sorrentino MA; Longoni HO; Luchetta PG; Dufour CD; Robinson AJ
    Medicina (B Aires); 1999; 59(4):327-31. PubMed ID: 10752195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation.
    del Cañizo C; Lopez N; Caballero D; Fernandez E; Brufau A; Vazquez L; Mateos V; Gutierrez N; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(9):901-5. PubMed ID: 10338045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery.
    del Cañizo MC; Lopez N; Vazquez L; Fernandez ME; Ana B; Caballero MD; Amigo ML; Mateos MV; Gutierrez N; San Migue JF
    Haematologica; 1999 Jun; 84(6):511-6. PubMed ID: 10366794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.